Home Translational Drug Development

Translational Drug Development

acquired
-
CRO Contract Research Organization

Basic Information

Translational Drug Development, as an oncology CRO (Contract Research Organization) dedicated to precision medicine, collaborates with innovative biotechnology and pharmaceutical companies to bring rare cancer treatments to patients as much as possible. As a TD2 client, you will have exclusive access to an integrated set of tools that maximize the chances of success for your research, along with a vast patient database that makes recruitment easier than ever before.
Translational Drug Development
Scottsdale,Arizona,United States of America
15~50 people
January 01, 2003
--